Skip to content

A Randomized Controlled Trial of a Herbal Compound for Improving Metabolic Parameters in Diabetic Patients with Uncontrolled Dyslipidemia.

Randomized controlled trial · Endocr Metab Immune Disord Drug Targets · 2019. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 30727929

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

A Randomized Controlled Trial of a Herbal Compound for Improving Metabolic Parameters in Diabetic Patients with Uncontrolled Dyslipidemia.

Ghorbani A, Zarvandi M, Rakhshandeh H
Endocr Metab Immune Disord Drug Targets · 2019

PubMed ID
30727929
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.